Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | P2RY8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | RBP5 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ENPP3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | TLR9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | DCP1B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | PLEKHA4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TF | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | CCDC14 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | BDNF | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | UBE2E3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |